This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.

Remote / online

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Miami
Condition: Bipolarity

View study

CompletedNCT00071721

Valproate in Dementia (VALID)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States
Sponsor: Alzheimer's Disease Cooperative Study (ADCS)
Condition: Schizophrenia

View study

CompletedNCT00194025

Valproate in Late Life Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 50 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Schizophrenia

View study

TerminatedNCT02343575

Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Stanford University
Condition: Schizophrenia

View study

WithdrawnNCT04047836

Vaping High vs. Low Nicotine E-Liquid

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherFrom 21 Years to 70 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Addiction

View study

CompletedNCT00492349

Varenicline Adjunctive Treatment in Schizophrenia

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

View study

TerminatedNCT01169610

Varenicline and Alcohol in Inpatient Addictions Program (IAP)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Addiction

View study

CompletedNCT02271919

Varenicline and Combined NRT for Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: M.D. Anderson Cancer Center
Condition: Addiction

View study

CompletedNCT00756275

Varenicline and Motivational Advice for Smokers With Substance Use Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Brown University
Condition: Addiction

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.